NO20051414L - Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger - Google Patents

Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger

Info

Publication number
NO20051414L
NO20051414L NO20051414A NO20051414A NO20051414L NO 20051414 L NO20051414 L NO 20051414L NO 20051414 A NO20051414 A NO 20051414A NO 20051414 A NO20051414 A NO 20051414A NO 20051414 L NO20051414 L NO 20051414L
Authority
NO
Norway
Prior art keywords
dry powder
preparation
powder inhalation
inhalation compositions
particulate
Prior art date
Application number
NO20051414A
Other languages
English (en)
Other versions
NO334076B1 (no
Inventor
Xian-Ming Zeng
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051414(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of NO20051414L publication Critical patent/NO20051414L/no
Publication of NO334076B1 publication Critical patent/NO334076B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for fremstilling av en tørrpulverinhalereringssammensetning som innbefatter en farmasøytisk akseptabel partikulær bærer, et første partikulært inhaleringsmedikament og et andre partikulært inhaleringsmedikament. Også tilveiebrakt er tøripulversammensetninger og fremgangsmåter for anvendelse av dem med en tørrpulverinhaleringsinnretning.
NO20051414A 2002-08-21 2005-03-18 Fremgangsmåte for fremstilling av tørrpulverinhaleringssammensetninger og multidose tørrpulverinhalator NO334076B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0219512.1A GB0219512D0 (en) 2002-08-21 2002-08-21 Inhalation compositions with high drug ratios
PCT/US2003/026542 WO2004017918A2 (en) 2002-08-21 2003-08-21 Method of preparing dry powder inhalation compositions

Publications (2)

Publication Number Publication Date
NO20051414L true NO20051414L (no) 2005-05-20
NO334076B1 NO334076B1 (no) 2013-12-02

Family

ID=9942745

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051414A NO334076B1 (no) 2002-08-21 2005-03-18 Fremgangsmåte for fremstilling av tørrpulverinhaleringssammensetninger og multidose tørrpulverinhalator

Country Status (16)

Country Link
US (1) US20060292083A1 (no)
EP (1) EP1545634B1 (no)
KR (1) KR101052693B1 (no)
CN (1) CN100379405C (no)
AU (1) AU2003258334B2 (no)
BR (1) BRPI0313764A2 (no)
CA (1) CA2499278C (no)
EA (1) EA007374B1 (no)
GB (1) GB0219512D0 (no)
MX (1) MXPA05001902A (no)
NO (1) NO334076B1 (no)
NZ (1) NZ538964A (no)
PT (1) PT1545634E (no)
TN (1) TNSN05046A1 (no)
WO (1) WO2004017918A2 (no)
ZA (1) ZA200502176B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ538965A (en) * 2002-08-21 2006-11-30 Norton Healthcare Ltd Dry powder inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
CA2575957C (en) 2003-09-02 2010-11-30 Norton Healthcare Ltd. Process for preparing a medicament
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
US7833979B2 (en) 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
EP2162540A2 (en) 2007-05-22 2010-03-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
GB0910537D0 (en) 2009-06-18 2009-07-29 Ivax Pharmaceuticals Ireland Inhaler
EP2538922B1 (en) * 2010-02-25 2016-04-06 Andi-Ventis Limited Formulation of compositions for the treatment of inflammatory conditions
PH12013501865A1 (en) 2011-03-16 2014-01-06 Amgen Inc Potent and selective inhibitors of nav1.3 and nav1.7
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
US20160067347A1 (en) 2012-12-20 2016-03-10 Amgen Inc. Apj receptor agonists and uses thereof
WO2014165277A2 (en) 2013-03-12 2014-10-09 Amgen Inc. POTENT AND SELECTIVE INHIBITORS OF Nav1.7
WO2015060743A1 (ru) * 2013-10-21 2015-04-30 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения болезней органов дыхания, содержащий в качестве активных веществ микронизированный салметерол ксинофоат и микронизированный флутиказона пропионат и способ его получения
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
UA118861C2 (uk) * 2013-12-06 2019-03-25 Оріон Корпорейшн Спосіб отримання сухих порошкових композицій для інгаляцій
WO2015191781A2 (en) 2014-06-10 2015-12-17 Amgen Inc. Apelin polypeptides
ES2776208T3 (es) 2015-12-03 2020-07-29 Tiefenbacher Alfred E Gmbh & Co Kg Procedimiento de mezcladura de polvo seco
US11318190B2 (en) 2017-05-05 2022-05-03 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating liver disease
SI3781126T1 (sl) 2018-04-16 2022-10-28 Ioulia Tseti Farmacevtska sestava suhih praškov za inhalacijo, ki vsebujejo ščitnični hormon
CN115364075B (zh) * 2022-09-16 2023-11-10 苏州易合医药有限公司 一种吸入颗粒组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US6103270A (en) * 1996-06-07 2000-08-15 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
AU5719798A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0876814A1 (en) * 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
AU2001226029A1 (en) * 2000-01-10 2001-07-24 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
US6369115B1 (en) * 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition

Also Published As

Publication number Publication date
ZA200502176B (en) 2006-05-31
NZ538964A (en) 2007-03-30
KR101052693B1 (ko) 2011-07-28
CN1681536A (zh) 2005-10-12
EP1545634A4 (en) 2009-09-09
KR20060052649A (ko) 2006-05-19
WO2004017918A9 (en) 2005-06-30
MXPA05001902A (es) 2005-04-28
EP1545634A2 (en) 2005-06-29
CA2499278C (en) 2013-03-19
AU2003258334B2 (en) 2009-03-05
WO2004017918A8 (en) 2005-05-12
EP1545634B1 (en) 2012-08-01
CN100379405C (zh) 2008-04-09
WO2004017918A2 (en) 2004-03-04
WO2004017918A3 (en) 2004-05-06
PT1545634E (pt) 2012-11-14
NO334076B1 (no) 2013-12-02
US20060292083A1 (en) 2006-12-28
CA2499278A1 (en) 2004-03-04
TNSN05046A1 (en) 2007-05-14
AU2003258334A1 (en) 2004-03-11
EA007374B1 (ru) 2006-10-27
BRPI0313764A2 (pt) 2018-11-21
EA200500388A1 (ru) 2005-12-29
GB0219512D0 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
NO20051414L (no) Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger
WO2005069933A3 (en) Methods of treating an inflammatory-related disease
WO2007087548A3 (en) Chemical compounds
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
ATE556704T1 (de) Pulverinhalator-formulierungen
PL371736A1 (en) Method for administering glp-1 molecules
EA200802390A1 (ru) Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
SE0200920D0 (sv) Novel compounds
SE9904505D0 (sv) Novel compounds
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
NO20052761L (no) Spirocykliske cykloheksanderivater.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
CU20080124A7 (es) Enmascaramiento del sabor de polvos
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
SE0103211D0 (sv) New formulations and use thereof
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
ATE233754T1 (de) Diphenyl-piperidin derivate
EP1379508A4 (en) N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
WO2003089449A3 (fr) Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective
IL181666A0 (en) Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees